CLINICAL_TRIALS
trial_result
· 2015-12-16
Clinical Trial Update: Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID [Phase 1]
Summary
Phase 1 interaction study completed in pulmonary hypertension patients on stable sildenafil therapy (20 mg three times daily).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 1 | Status: COMPLETED